Thursday, March 7, 2013
A double-blind, randomized, placebo-controlled, clinical trial to test the efficacy of Epoetin alfa on physical performance of Friedreich Ataxia patients (FriEMax).
A double-blind, randomized, placebo-controlled, clinical trial to test the efficacy of Epoetin alfa on physical performance of Friedreich Ataxia patients (FriEMax). FARA, Clinical Trial Newsletter, March 2013
